✦ LIBER ✦

The contribution of neuropsychological and clinical-epidemiological variables in the prediction of treatment outcome in obsessive-compulsive disorder

✍ Scribed by P. Cavedini; A. Ubbiali; A. Gorini; C. Zorzi; T. Bassi; S. Giordani; A. D'Annucci

Book ID: 119576329
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 128 KB
Volume: 12
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(02)80573-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The impact of neuropsychological functio

The impact of neuropsychological functioning on treatment outcome in pediatric obsessive–compulsive disorder

✍ Christopher A. Flessner; Amy Allgair; Abbe Garcia; Jennifer Freeman; Jeffrey Sap 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 1 views

Refining clinical judgment of treatment

Refining clinical judgment of treatment outcome in obsessive–compulsive disorder

✍ Adam B. Lewin; Alessandro S. De Nadai; Jennifer Park; Wayne K. Goodman; Tanya K. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 371 KB

The clinical outcome of neurosurgical tr

The clinical outcome of neurosurgical treatment in obsessive-compulsive disorder: A review

✍ Hay, P. 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Neuropsychological Performance in Childr

Neuropsychological Performance in Children and Adolescents with Obsessive-Compulsive Disorder and Influence of Clinical Variables

✍ Susana Andrés; Teresa Boget; Luisa Lázaro; Rafael Penadés; Astrid Morer; Manel S 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 107 KB

CLINICAL PREDICTORS OF LONG-TERM OUTCOME

CLINICAL PREDICTORS OF LONG-TERM OUTCOME IN OBSESSIVE-COMPULSIVE DISORDER

✍ Jakubovski, Ewgeni; Diniz, Juliana B.; Valerio, Carolina; Fossaluza, Victor; Bel 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 313 KB

SSRIs in the Treatment of obsessive-comp

SSRIs in the Treatment of obsessive-compulsive disorder

✍ Charles Cartwright; Eric Hollander 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB 👁 2 views

The introduction of the SSRIs (selective serotonin reuptake inhibitors) over the past decade has provided exciting new opportunities for the treatment of obsessive-compulsive disorder (OCD). The serotonin hypothesis, based on the preferential response of OCD to the serotonin reuptake inhibitor, clom